256 related articles for article (PubMed ID: 24408015)
1. Microsatellite instability and promoter hypermethylation in colorectal cancer in India.
Kanth VV; Bhalsing S; Sasikala M; Rao GV; Pradeep R; Avanthi US; Reddy DN
Tumour Biol; 2014 May; 35(5):4347-55. PubMed ID: 24408015
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.
Ashktorab H; Smoot DT; Farzanmehr H; Fidelia-Lambert M; Momen B; Hylind L; Iacosozio-Dononue C; Carethers JM; Goel A; Boland CR; Giardiello FM
Int J Cancer; 2005 Oct; 116(6):914-9. PubMed ID: 15856472
[TBL] [Abstract][Full Text] [Related]
3. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects.
Ashktorab H; Brim H; Al-Riyami M; Date A; Al-Mawaly K; Kashoub M; Al-Mjeni R; Smoot DT; Al-Moundhri M; Al-Hashemi S; Ganguly SS; Raeburn S
Dig Dis Sci; 2008 Oct; 53(10):2723-31. PubMed ID: 18299982
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer.
Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R
J BUON; 2011; 16(2):265-73. PubMed ID: 21766496
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer.
Arnold CN; Goel A; Compton C; Marcus V; Niedzwiecki D; Dowell JM; Wasserman L; Inoue T; Mayer RJ; Bertagnolli MM; Boland CR
Cancer Biol Ther; 2004 Jan; 3(1):73-8. PubMed ID: 14726676
[TBL] [Abstract][Full Text] [Related]
6. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
7. The profile of hMLH1 methylation and microsatellite instability in colorectal and non-small cell lung cancer.
Okuda T; Kawakami K; Ishiguro K; Oda M; Omura K; Watanabe G
Int J Mol Med; 2005 Jan; 15(1):85-90. PubMed ID: 15583832
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
[TBL] [Abstract][Full Text] [Related]
9. Comparative features of colorectal and gastric cancers with microsatellite instability in Chinese patients.
Huang YQ; Yuan Y; Ge WT; Hu HG; Zhang SZ; Zheng S
J Zhejiang Univ Sci B; 2010 Sep; 11(9):647-53. PubMed ID: 20803768
[TBL] [Abstract][Full Text] [Related]
10. Assessment of microsatellite instability in colorectal carcinoma at an Indian center.
Pandey V; Prabhu JS; Payal K; Rajan V; Deepak C; Barde S; Jagannath P; Borges A; Sridhar TS
Int J Colorectal Dis; 2007 Jul; 22(7):777-82. PubMed ID: 17160686
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics of colorectal cancer with family history: an evaluation of family history as a predictive factor for microsatellite instability.
Park IJ; Kim HC; Yoon YS; Yu CS; Jang SJ; Kim JC
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S91-7. PubMed ID: 17923762
[TBL] [Abstract][Full Text] [Related]
12. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
[TBL] [Abstract][Full Text] [Related]
15. [Study of germline mutation of hMSH2, hMSH6 and hMLH1 and methylation of hMLH1 in microsatellite instability colorectal cancer].
Ni M; Jin HY; Ding YJ; Liu F; Ding SQ; Fan ZM; Wang YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):358-61. PubMed ID: 18636359
[TBL] [Abstract][Full Text] [Related]
16. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
17. Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability.
Gologan A; Krasinskas A; Hunt J; Thull DL; Farkas L; Sepulveda AR
Arch Pathol Lab Med; 2005 Nov; 129(11):1390-7. PubMed ID: 16253017
[TBL] [Abstract][Full Text] [Related]
18. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
[TBL] [Abstract][Full Text] [Related]
19. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mutator pathway in younger-age-onset colorectal adenocarcinomas.
Roh SA; Kim HC; Kim JS; Kim JC
J Korean Med Sci; 2003 Jun; 18(3):387-91. PubMed ID: 12808326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
